Overview
Status
Active
Registry date
2022-10-04
Share capital
50,000.00 PLN
Registered address
Aleja Słowiańska 25/7, 01-695 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 8 days early.
- 202514/07/2026
- 202430/06/2025
- 202307/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 43.47kMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD -664.72MedianUSD 14.31kAverageUSD 129.52k
Operating costs
This companyUSD 44.14kMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 77.56kMedianUSD 173.92kAverageUSD 1.02m
Industry
Authorized Representatives
Agata Jolanta Żołnierczyk – Attorney-in-fact (sole)
Piotr Stefan Żołnierczyk – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agata Jolanta Żołnierczykage 57 | 25 | $1,350.62 | 10% |
Piotr Stefan Żołnierczykage 67 | 225 | $12,155.59 | 90% |
Piotr Stefan Żołnierczyk and Agata Jolanta Żołnierczyk hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-10-04.
74 1020 1026 0000 1902 0548 7709
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nectar Polskasp. z o.o. | $528,123.00 | klinikametoda.pl | ||
| Astimedsp. z o.o. | $498,540.18 | astimed.pl | ||
| I. V. Clinicsp. z o.o. | $510,444.80 | ivclinic.com.pl | ||
| MAAMsp. z o.o. | $455,593.52 | urmed.pl | ||
| Saska Medsp. z o.o. | $241,826.45 | saskamed.pl | ||
| Promindsp. z o.o. | $89,181.48 | promindclinic.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Biocells Medicalsp. z o.o. | $11,508.17 | biocellsmedical.com | ||
| Bodyclinicsp. z o.o. | $3,758.46 | bodyclinic.pl | ||
| Regenerumclinicsp. z o.o. | $1,427.86 | regenerumclinic.pl |
FAQ
The main business activity of Endofem focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on October 4, 2022.
The headquarters is located at: Aleja Słowiańska 25, 01-695 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $37,999 in 2024, which is an increase of 56.8% compared to 2023.
No, the company recorded a net loss of $3,002 in 2024. For comparison, in 2023 the loss was $29,454, meaning the company reduced its loss by 90.3%.
The largest operating cost category falls under other operating costs. This category amounted to $21,323 in 2024, representing 52% of all operating expenses.
Last updated: 2026-07-17